Cutaneous squamous-cell carcinoma in patients treated with PUVA. 1984

R S Stern, and N Laird, and J Melski, and J A Parrish, and T B Fitzpatrick, and H L Bleich

A 5.7-year prospective study of 1380 patients treated for psoriasis with oral methoxsalen (8-methoxypsoralen) and ultraviolet A photochemotherapy (PUVA) revealed that after adjustment for exposures to ionizing radiation and topical tar preparations, the risk that cutaneous squamous-cell carcinoma would develop at least 22 months after the first exposure to PUVA was 12.8 times higher in patients exposed to a high dose than in those exposed to a low dose (95 per cent confidence interval, 5.8 to 28.5). No substantial dose-related increase was noted for basal-cell carcinoma. The dose-dependent risk of cutaneous squamous-cell carcinoma suggests that PUVA can act as an independent carcinogen. In our study, morbidity associated with these tumors has been limited, but further follow-up is needed. Meanwhile, patients treated with PUVA should be followed closely for the possible development of cutaneous squamous-cell carcinoma.

UI MeSH Term Description Entries
D008297 Male Males
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D011336 Probability The study of chance processes or the relative frequency characterizing a chance process. Probabilities
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D011701 PUVA Therapy Photochemotherapy using PSORALENS as the photosensitizing agent and ultraviolet light type A (UVA). Psoralen Ultraviolet A Therapy,Therapy, PUVA,PUVA Therapies,Therapies, PUVA
D002280 Carcinoma, Basal Cell A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471) Carcinoma, Basal Cell, Pigmented,Epithelioma, Basal Cell,Rodent Ulcer,Ulcer, Rodent,Basal Cell Carcinoma,Basal Cell Carcinomas,Basal Cell Epithelioma,Basal Cell Epitheliomas,Carcinomas, Basal Cell,Epitheliomas, Basal Cell,Rodent Ulcers,Ulcers, Rodent
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females

Related Publications

R S Stern, and N Laird, and J Melski, and J A Parrish, and T B Fitzpatrick, and H L Bleich
March 1984, The British journal of dermatology,
R S Stern, and N Laird, and J Melski, and J A Parrish, and T B Fitzpatrick, and H L Bleich
August 1995, Photodermatology, photoimmunology & photomedicine,
R S Stern, and N Laird, and J Melski, and J A Parrish, and T B Fitzpatrick, and H L Bleich
February 1985, Photo-dermatology,
R S Stern, and N Laird, and J Melski, and J A Parrish, and T B Fitzpatrick, and H L Bleich
November 2016, The Journal of investigative dermatology,
R S Stern, and N Laird, and J Melski, and J A Parrish, and T B Fitzpatrick, and H L Bleich
December 2020, Actas dermo-sifiliograficas,
R S Stern, and N Laird, and J Melski, and J A Parrish, and T B Fitzpatrick, and H L Bleich
May 2021, Actas dermo-sifiliograficas,
R S Stern, and N Laird, and J Melski, and J A Parrish, and T B Fitzpatrick, and H L Bleich
January 2005, European journal of dermatology : EJD,
R S Stern, and N Laird, and J Melski, and J A Parrish, and T B Fitzpatrick, and H L Bleich
July 2017, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG,
R S Stern, and N Laird, and J Melski, and J A Parrish, and T B Fitzpatrick, and H L Bleich
January 1992, Dermatology (Basel, Switzerland),
R S Stern, and N Laird, and J Melski, and J A Parrish, and T B Fitzpatrick, and H L Bleich
October 1994, Lancet (London, England),
Copied contents to your clipboard!